Summary

Ceres Power (LSE:CWR) is a British licensor of solid oxide fuel cell and electrolyser technology, earning royalties from partners including Doosan, Delta, Denso, Shell and Thermax. After a weaker 2025, whether global partnerships can reignite the shares hinges on those licensees moving from pilots into volume manufacturing and paying royalties.

Five Key Takeaways

  • Ceres Power runs an asset-light licensing model, earning fees and royalties as partners manufacture its solid oxide fuel cells and electrolysers rather than building factories itself.
  • Full-year 2025 revenue fell sharply year on year, but the company generated its first royalties as Doosan began mass production in South Korea.
  • A substantial cash balance gives Ceres an unusually strong balance sheet for a clean-energy developer, funding continued investment while losses remain wide.
  • New and expanded partnerships across Asia, including Delta, Weichai, Denso, Shell and Thermax, broaden the routes through which royalties could eventually flow.
  • The investment case depends on licensees reaching commercial scale; slow final decisions, policy shifts and a cash-consuming business remain the central risks.

Company Overview

Ceres Power Holdings plc (LSE:CWR) is a British clean-energy technology company that develops and licenses solid oxide fuel cell and solid oxide electrolysis technology. Rather than building large factories of its own, Ceres operates an asset-light model: it perfects its core technology at its facilities in the United Kingdom, then licenses the designs and know-how to major industrial partners who manufacture and deploy products at scale. In return, Ceres receives upfront licence fees, engineering-service income and, ultimately, royalties on every unit its partners sell. The appeal of this approach is that it seeks to capture the value of intellectual property while transferring the heavy capital cost, and much of the manufacturing risk, onto larger, better-resourced industrial partners spread across several continents.

The company's fuel cell platform, known as the SteelCell, converts fuel such as hydrogen or natural gas into electricity efficiently and with fewer exotic materials than many rival designs. The same underlying stack technology can be run in reverse as a solid oxide electrolyser, or SOEC, splitting water into hydrogen using high-temperature steam. Ceres argues this dual-purpose capability, spanning both power generation and green hydrogen production, gives it two large addressable markets from a single technology base.

A licensing model built on partners

Because Ceres depends on licensees to commercialise its technology, its progress is best measured by the strength and momentum of those relationships. Over recent years the company has assembled an international roster spanning South Korea, Taiwan, China, Japan and India, positioning it as a technology enabler to some of the world's largest industrial groups rather than a direct manufacturer competing for factory orders.

What Has Happened Recently?

In March 2026 Ceres reported results for the year ended 31 December 2025. Revenue fell to £32.6 million, down from £51.9 million a year earlier, a decline of roughly 37 per cent that reflected the lumpy, milestone-driven nature of licensing income. Gross margin remained high at around 70 per cent, and the company reported an adjusted EBITDA loss of £32.5 million and a wider net loss of £47.5 million.

Alongside the softer headline numbers came a symbolically important milestone: Ceres generated its first royalties, some £110,000, as partner Doosan began mass production of fuel cell systems in South Korea. Though modest, this marked the point at which the licensing model started to convert manufacturing activity into recurring royalty income for the first time.

The period also brought a strategic setback. In February 2025 Bosch, a long-standing shareholder and licensee, confirmed it would wind down its own solid oxide fuel cell activities as part of a wider repositioning. Ceres has framed the year as one of restructuring and refocusing, reducing its headcount to around 353 people from 546 and targeting a roughly 20 per cent reduction in operating costs by the end of 2026. Management has presented these measures as a deliberate reset, intended to align the cost base with a more focused set of partnerships and to preserve cash while the licensing model matures.

Why the Stock Is Attracting Attention

Ceres attracts attention because it sits at the intersection of two structural themes: the electrification of power and the emergence of green hydrogen. Its licensing model is unusual among clean-energy names, promising high-margin, capital-light income if partners succeed, without Ceres having to fund the enormous cost of building gigawatt-scale factories itself.

The stock has been volatile. Having de-rated heavily from its pandemic-era highs, the shares reacted positively to the 2025 results and to management's message of a longer cash runway and disciplined execution, even as revenue fell. For investors, the central question is whether a broadening base of global partners can turn years of engineering promise into a self-sustaining royalty stream.

Asia at the centre of the story

Much of the renewed interest reflects momentum in Asia. Doosan is in production in South Korea, Delta Electronics is investing heavily in Taiwan, Weichai signed a fresh manufacturing licence in China in late 2025, and Denso, Shell and Thermax are advancing electrolyser projects across Japan and India. Each represents a potential future royalty channel, and collectively they diversify Ceres away from reliance on any single partner or geography.

Principal Projects, Products or Operations

Ceres's operations revolve around its partner programmes. In South Korea, Doosan operates a 50MW fuel cell facility and has begun producing stacks, triggering the company's first royalties. In Taiwan, Delta Electronics has been acquiring land and facilities, reported at around £170 million of investment, with pilot production targeted by the end of 2026, a step that could materially expand manufacturing capacity for Ceres technology.

On the electrolysis side, the company has made visible progress. A one-megawatt solid oxide electrolyser demonstrator built with Shell in India exceeded performance expectations, achieving what Ceres described as class-leading efficiency of around 37 kilowatt-hours per kilogram of hydrogen. In Japan, Denso is running an electrolysis demonstration at a JERA thermal power station under a large, government-supported programme, while in India Thermax has broken ground on a solid oxide electrolyser pilot plant. Taken together, these projects span three of Asia's largest industrial economies and cover both the fuel cell and hydrogen sides of the business, illustrating how widely Ceres has sought to seed its technology.

One platform, two markets

Central to the strategy is a dual-purpose stack platform that supports both fuel cell and electrolysis applications. By serving stationary power generation and green hydrogen production from the same core technology, Ceres aims to maximise the value of each partnership and spread its research and development effort across a wider set of end markets and customers.

Latest Financial Position

Ceres ended 2025 with cash and short-term investments of £83.3 million, down from £102.5 million a year earlier. For a company of its stage that remains a comparatively robust balance sheet, and management has repeatedly emphasised a disciplined approach to cash and a runway that it believes supports the business through its commercialisation phase without immediate reliance on external funding.

That said, the group remains loss-making and cash-consuming. The adjusted EBITDA loss of £32.5 million and net loss of £47.5 million underline that royalties are still in their infancy. The company has guided to contracted group revenue of approximately £45 million for 2026 before any new business is signed, suggesting a recovery from the 2025 dip, though licensing revenue can be uneven from year to year.

Balancing investment and prudence

The combination of a sizeable cash pile, high gross margins and a cost-reduction programme is designed to extend the runway while partners scale up. The key financial tension is straightforward: Ceres must fund continued development and support its licensees long enough for royalty income to grow into a meaningful, recurring contribution before its cash reserves are materially depleted.

Potential Growth Catalysts

The clearest catalyst would be a marked increase in royalty income as partners move from pilots into volume manufacturing. Doosan's early royalties, Delta's pilot production targeted for late 2026 and Weichai's new licence in China each offer routes through which recurring revenue could build over the coming years if commercial ramp-ups proceed.

Electrolysis represents a second leg of potential growth. Successful demonstrations with Shell, Denso and Thermax could pave the way toward larger commercial deployments in green hydrogen, a market underpinned by decarbonisation policy in Europe, Japan, India and beyond. Government support, such as the substantial subsidies attached to the JERA project in Japan, can accelerate these timelines.

New licences and milestones

Additional catalysts include the signing of entirely new licence agreements, further milestone payments from existing partners, and evidence that manufacturing yields and product performance meet commercial standards. Each new partner or expanded programme both diversifies Ceres's income base and validates its technology to the wider market, potentially supporting sentiment toward the shares.

Material Risks and Challenges

The most fundamental risk is that Ceres does not control its own path to commercial scale. It depends on licensees to invest, build factories and sell products, and their strategic priorities can change, as Bosch's withdrawal from solid oxide fuel cells in early 2025 demonstrated. Delays to partners' final investment decisions or production ramps directly delay royalties.

Financially, the group is still lossmaking and consumes cash. While the balance sheet is strong today, a prolonged commercialisation timeline would erode reserves and could eventually raise questions about future funding. Licensing revenue is also inherently lumpy, making reported results volatile and harder for the market to forecast with confidence.

Policy and competition

Both fuel cells and green hydrogen remain heavily influenced by government policy and subsidy regimes, which can shift with political and economic cycles. Ceres also competes with alternative fuel cell and electrolyser technologies, and with well-funded rivals. Currency movements and the concentration of activity among a small number of large partners add further uncertainty to the outlook.

What Investors Should Monitor Next

The single most important metric to watch is royalty income and how quickly it grows beyond the initial £110,000 recorded in 2025. A clear, sustained upward trend would be the strongest evidence that the licensing model is finally working as intended and that partnerships are translating into recurring cash.

Investors should also track partner milestones: whether Delta hits its late-2026 pilot production target, how Doosan's South Korean output scales, progress on the Weichai licence in China, and whether the Shell, Denso and Thermax electrolyser projects advance toward commercial orders. Any new licence agreements would be similarly significant.

Cash and guidance

Finally, the trajectory of cash consumption, delivery against the 2026 contracted revenue guidance of around £45 million, and progress on the planned cost reductions will indicate how well management is balancing investment against prudence. Together these signals will show whether Ceres is moving closer to, or further from, self-sustaining profitability.

Balanced Conclusion

Ceres Power (LSE:CWR) presents a finely balanced picture. On one hand, it owns differentiated dual-purpose technology, commands high gross margins, holds a substantial cash cushion and has assembled an impressive roster of global industrial partners spanning South Korea, Taiwan, China, Japan and India. The arrival of first royalties, however small, is a genuine milestone for its licensing strategy.

On the other hand, 2025 saw revenue fall sharply, losses widen and a significant partner exit the technology, underlining how dependent Ceres remains on others to reach commercial scale. Whether global partnerships can reignite the stock is therefore not yet settled: the potential is real, but so is the execution risk. For now, the company remains a long-duration, catalyst-driven story whose ultimate success rests on partners converting pilots into volume, royalty-paying production over the years ahead. Patient investors will be weighing the strength of the technology and the balance sheet against the reality that timing rests largely with the partners.

Catalysts and Risks at a Glance

Potential Catalysts

Material Risks

Royalty income scaling up as Doosan and other partners move into volume production

Royalties still tiny and dependent on partners' own investment and timelines

Delta Electronics pilot production in Taiwan targeted for the end of 2026

Delays to partners' final investment decisions directly delay Ceres's income

Electrolyser demonstrations with Shell, Denso and Thermax advancing toward commercial scale

Green hydrogen economics remain policy-dependent and unproven at large scale

Strong cash balance funding continued development and partner support

Group remains loss-making and cash-consuming with a long path to profit

New licence agreements diversifying the royalty base across regions

Concentration among a few large partners; a key licensee could exit, as Bosch did

Government subsidies, such as Japan's JERA programme, accelerating deployment

Lumpy licensing revenue makes results volatile and hard to forecast